Therapeutic angiogenesis: a step forward in intermittent claudication.
Donnelly
Richard
R
School of Medical and Surgical Sciences, University of Nottingham, UK. Richard.donnelly@nottingham.ac.uk
Yeung
Justin M C
JM
D000368:Aged; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply; D008297:Male; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D016032:Randomized Controlled Trials as Topic
D016222:Fibroblast Growth Factor 2